GLUT1 Inhibitors

GLUT1 inhibitors are a class of pharmaceutical compounds that target the GLUT1 transporter protein which plays a key role in glucose uptake in cells By inhibiting GLUT1 these inhibitors can effectively limit glucose uptake and metabolism in specific tissues or cell types This targeted inhibition has significant potential in the treatment of various diseases including cancer where high glucose utilization is a hallmark By suppressing glucose uptake through GLUT1 inhibition these inhibitors have the potential to impair tumor growth and increase the efficacy of other cancer therapies Our company offers a range of high-quality GLUT1 inhibitors for biomedical research and therapeutic applications

Catalog Number	Chemical Name	CAS #	Price
BC-0150	Resveratrol	501-36-0	Online Inquiry
BC-0616	Naringenin	480-41-1	Online Inquiry
EI-0348	BAY-876	1799753-84-6	Online Inquiry
EI-0969	Fasentin	392721-37-8	Online Inquiry
EI-1929	Rubusoside	64849-39-4	Online Inquiry
EI-2065	STF-31	724741-75-7	Online Inquiry
EI-2315	WZB117	1223397-11-2	Online Inquiry

Application

GLUT1 inhibitors offer valuable applications in medical research and potential therapeutic interventions Researchers can utilize these inhibitors to study the role of glucose transporters in various cellular processes such as energy metabolism and cancer cell proliferation By inhibiting GLUT1 scientists can better understand the impact of glucose availability on cellular functions and potentially develop new strategies for targeting cancer cells that heavily rely on glucose

In the field of drug development GLUT1 inhibitors show promise as potential anticancer agents Cancer cells often exhibit an increased reliance on glucose for their rapid growth and proliferation By targeting GLUT1 these inhibitors can disrupt the glucose uptake by cancer cells potentially inhibiting their growth and survival This application holds great hope for the development of more effective and targeted therapies in the fight against cancer

Furthermore GLUT1 inhibitors offer important applications in metabolic disorders particularly in the management of Type 2 diabetes By inhibiting glucose transporters these inhibitors can reduce the uptake of glucose into cells helping to regulate blood sugar levels This can contribute to better control of diabetes symptoms and potentially reduce the risk of complications associated with the condition

In summary GLUT1 inhibitors hold immense potential for research advancements and therapeutic interventions in understanding and addressing various diseases including cancer and metabolic disorders Their ability to target glucose transporters opens up new avenues for exploring cellular processes and developing innovative treatment strategies

Please note that all services are for research use only. Not intended for any clinical use.

GLUT1 Inhibitors